Keenan Greg 4
4 · Aurinia Pharmaceuticals Inc. · Filed Aug 5, 2025
Insider Transaction Report
Form 4
Keenan Greg
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2025-08-01$10.50/sh−20,000$210,000→ 133,484 total
Footnotes (1)
- [F1]The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.48 to $10.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.